stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) Operating margin
Liquidia Corporation's operating margin over the twelve months to 30 June 2026 was 37.4%, up 69.8 percentage points from fiscal 2025 (−32.5%). Over the past ten years it has ranged from −15,978.7% (fiscal 2020) to −32.5% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −32.5% | 834.18 |
| FY2024 | −866.6% | (447.01) |
| FY2023 | −419.6% | (176.32) |
| FY2022 | −243.3% | 243.30 |
| FY2022 | −486.6% | (223.65) |
| FY2021 | −263.0% | 172.93 |
| FY2021 | −435.9% | 7,553.45 |
| FY2020 | −7,989.3% | 7,989.33 |
| FY2020 | −15,978.7% | (15,398.59) |
| FY2019 | −580.1% | 580.06 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 49.8% | 3.52 |
| Mar 2026 | 46.3% | 24.79 |
| Dec 2025 | 21.5% | 18.25 |
| Sep 2025 | 3.25% | 427.66 |
| 32 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | 40.6% |
| LQDA Liquidia Corporation | 37.4% |
| PBH Prestige Consumer Healthcare Inc. compare | 25.0% |
| LNTH Lantheus Holdings, Inc. compare | 18.6% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 15.0% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.00% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.00% |
| HIMS Hims & Hers Health, Inc. compare | −5.99% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement